Sapience Investments, LLC - SYNEOS HEALTH INC ownership

SYNEOS HEALTH INC's ticker is SYNH and the CUSIP is 87166B102. A total of 355 filers reported holding SYNEOS HEALTH INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sapience Investments, LLC ownership history of SYNEOS HEALTH INC
ValueSharesWeighting
Q1 2023$6,328,962
-9.0%
177,680
-6.3%
1.46%
+0.1%
Q4 2022$6,958,196
-33.4%
189,700
-14.4%
1.46%
-33.4%
Q3 2022$10,448,000
+3.0%
221,594
+56.6%
2.19%
+15.5%
Q2 2022$10,140,000
-20.1%
141,462
-9.8%
1.90%
+23.2%
Q1 2022$12,695,000
-24.4%
156,825
-4.1%
1.54%
-19.4%
Q4 2021$16,791,000
+15.5%
163,525
-1.6%
1.91%
+10.8%
Q3 2021$14,536,000
-10.9%
166,165
-8.8%
1.73%
-14.8%
Q2 2021$16,313,000
+0.4%
182,285
-14.9%
2.03%
-0.6%
Q1 2021$16,248,000
-3.3%
214,217
-13.1%
2.04%
-12.7%
Q4 2020$16,795,000
+37.0%
246,510
+6.9%
2.34%
+7.4%
Q3 2020$12,255,000
+22.6%
230,530
+34.3%
2.18%
+18.3%
Q2 2020$9,997,000
+4.3%
171,630
-29.4%
1.84%
-13.7%
Q1 2020$9,584,000
-13.4%
243,125
+30.7%
2.13%
+37.8%
Q4 2019$11,066,000
+5.9%
186,060
-5.3%
1.55%
+6.5%
Q3 2019$10,450,000
-47.6%
196,400
-49.7%
1.45%
-46.5%
Q2 2019$19,950,000
+21.4%
390,490
+22.9%
2.72%
+24.2%
Q1 2019$16,440,000
+10.0%
317,615
-16.4%
2.19%
-10.3%
Q4 2018$14,950,000
-20.1%
379,935
+4.7%
2.44%
+6.7%
Q3 2018$18,712,000
-48.8%
362,980
-53.4%
2.28%
-5.5%
Q2 2018$36,544,000
+67.8%
779,180
+27.0%
2.42%
-19.0%
Q1 2018$21,772,000613,3002.98%
Other shareholders
SYNEOS HEALTH INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alpine Peaks Capital, LP 115,018$4,096,9413.09%
Kent Lake Capital LLC 71,744$2,555,5211.73%
Sapience Investments, LLC 177,680$6,328,9621.46%
Clearline Capital LP 260,696$9,285,9911.40%
Sessa Capital IM, L.P. 912,586$32,506,3131.23%
MARTIN & CO INC /TN/ 97,897$3,487,0910.90%
REINHART PARTNERS, LLC. 428,426$15,260,5500.83%
BOULDER HILL CAPITAL MANAGEMENT LP 20,800$740,8960.60%
Polianta Ltd 34,500$1,2280.56%
EARNEST PARTNERS LLC 2,593,508$92,380,7550.53%
View complete list of SYNEOS HEALTH INC shareholders